MoneyWorks4Me

SMS Pharmaceuticals informs about disclosure of related party transactions

24 Jun 2021 Evaluate

In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has informed that it has enclosed the disclosure of Related Party Transactions on a consolidated basis, in the form at specified in the accounting standards for the half year ended 31st March, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..